NeueHealth, Inc.
NEUE · NYSE
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -3.1% | -7.2% | -0.1% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 30% | 25.4% | 20.5% | 21.6% |
| EBITDA | $0 | $0 | -$0 | -$0 |
| % Margin | 8.3% | 4.1% | -14.3% | -6.1% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -11.2% | -5.4% | -1.2% | -24.6% |
| EPS Diluted | -2.63 | -2.9 | -1.94 | -8.51 |
| % Growth | 9.3% | -49.5% | 77.2% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |